DrugAug 30, 2023
Parker Laboratories Helix CBD Clinical Cream (Menthol 7.4%) recall — FDA D-1093-2023
CGMP Deviations
Class IIFDA: TerminatedParker Laboratories, Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 53
10,685 detailed records are currently available in this category.
DrugAug 30, 2023
Parker Laboratories Protex Foaming Hand Sanitizer recall — FDA D-1089-2023
CGMP Deviations
Class IIFDA: TerminatedParker Laboratories, Inc.
DrugAug 30, 2023
Ecometics YAGER'S LINIMENT recall — FDA D-1097-2023
CGMP Deviations: Products not manufactured under current good manufacturing practices.
Class IIFDA: CompletedEcometics, Inc.
DrugAug 23, 2023
Colgate Palmolive Company hello wild strawberry fluoride toothpaste, sodium fluoride 0.24% recall — FDA D-1084-2023
Labeling: Label Mix-Up: Some hello wild strawberry fluoride toothpaste, packaged in cartons labeled as hello wild strawberry fluoride toothpaste were incorrectly filled in tubes labeled as…
Class IIFDA: TerminatedColgate Palmolive Company
DrugAug 23, 2023
Advanced Accelerator Applications USA PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 recall — FDA D-1085-2023
Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date
Class IIIFDA: TerminatedAdvanced Accelerator Applications USA, Inc.
DrugAug 16, 2023
Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle recall — FDA D-1082-2023
Out of Specification result observed in content uniformity testing
Class IIIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugAug 16, 2023
SODIUM CHLORIDE 0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container recall — FDA D-1083-2023
Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.
Class IIIFDA: TerminatedB. Braun Medical Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (trophamine) recall — FDA D-1002-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services vancomycin 1.5 g/250mL added to 5% dextrose, 6 mg/mL, IV recall — FDA D-0968-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL recall — FDA D-1058-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Tydemy recall — FDA D-1081-2023
Failed Stability Specification and Failed Impurities/Degradation Specifications: out of specification for inactive content ascorbic acid and MTHFRC-7impurity test
Class IFDA: TerminatedLupin Pharmaceuticals Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services morphine in 0.9% sodium chloride, 125 mg/25 mL recall — FDA D-1068-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL recall — FDA D-1063-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL recall — FDA D-1075-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe recall — FDA D-1043-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services CARDIOPLEGIA SOLUTION, 108 mEq K, Induction 8:1, High recall — FDA D-1032-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag recall — FDA D-1051-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services oxyTOCIN 30 units added to Lactated Ringer's 500 mL, IV recall — FDA D-1012-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (trophamine) recall — FDA D-1001-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services CARDIOPLEGIA SOLUTION, 15 mEq K, Reperfusate 4:1, low recall — FDA D-1022-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 recall — FDA D-1052-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL recall — FDA D-1077-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services CARDIOPLEGIA SOLUTION, 48 mEq K, Induction 4:1 in recall — FDA D-1024-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services phenylephrine, 25mg added to 0.9% sodium chloride 250 recall — FDA D-0962-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.